Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Meningoencephalitis; acute pulmonary failure; This is a spontaneous report downloaded from the Regulatory Authority-WEB, regulatory authority number: DE-PEI-PEI2021003222. A 54-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection), via an unspecified route of administration from 06Mar2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 06Mar2021 patient experienced meningoencephalitis (death), acute pulmonary failure (death) on 06Mar2021. Seriousness of the case was death. Outcome of the both events was fatal. The patient died on 08Mar2021. It was not reported if an autopsy was performed. No follow-up attempts needed, follow-up automatically provided by regulatory authority.; Reported Cause(s) of Death: acute pulmonary failure; Meningoencephalitis
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166